Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
Wisconsin Roundup: VictorySpark, Imbed, Virent, Cellectar, & More 09/09/14 Wisconsin
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B 08/25/13 San Francisco
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs 05/09/13 Boston
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
Onyx Drug Effective in New Myeloma Patients, Taking Aim at Millennium 12/12/11 San Francisco
Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A 09/12/11 Boston
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Onyx Unveils Results for Myeloma Drug, Raising Stakes in Rivalry with Millennium 12/07/10 San Francisco
Glaxo Ends Resveratrol Drug Study 12/01/10 Boston
Onyx Delays Cancer Drug Application as FDA Asks for More Data on Manufacturing 10/07/10 San Francisco
Onyx Pockets $59M Upfront From Japanese Partner, to Market Myeloma Drugs 09/08/10 San Francisco
LS9 Reveals Key Biofuel Genes, Onyx Drug Passes Big Trial, Solazyme Seeks First-Mover Edge, & More Bay Area Life Sciences News 07/30/10 San Francisco
Onyx Preps for Dash to FDA, After Myeloma Drug Helps Sickest of the Sick 07/26/10 San Francisco
Page 1 of 2 next page »